
GC73965
INX-315
Also known as 4-[(12-oxospiro[1,3,5,10,11-pentazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-4-yl)amino]benzenesulfonamide
INX-315 is an orally active and selective CDK2 inhibitor that induces cell cycle arrest in the G1 phase
ChemicalCAS2745060-92-6MW427.48FormulaC19H21N7O3S
- CAS number
- 2745060-92-6
- Molecular weight
- 427.48
- Formula
- C19H21N7O3S
- Solubility
- DMSO : 100 mg/mL (233·93 mM; Need ultrasonic)
- InChIKey
- KGJVKYSVVOQPDL-UHFFFAOYSA-N
- Catalogue number
- GC73965
- Brand
- GLPBIO
Computed properties PubChem CID 162360412 · XLogP 2.4 · TPSA 152 Ų · H-bond donors 4
- XLogP
- 2.4
- TPSA
- 152 Ų
- H-bond donors
- 4
- H-bond acceptors
- 8
- Rotatable bonds
- 3
- Heavy atoms
- 30
SMILES C1CCC2(CC1)C(=O)NNC3=CC4=CN=C(N=C4N23)NC5=CC=C(C=C5)S(=O)(=O)N
Computed descriptors from PubChem (CID 162360412), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il